Quarter Comparison
Revenue
Operating Income
Gross Margin
Net Margin
Income Statement
Balance Sheet
Earnings Release
EX-99.1 2 agl-20260630xexx991.htm EX-99.1 Document Exhibit 99.1 agilon health Reports Second Quarter 2026 Results Revenue increase 7% to $1.49 billion Raises Full-Year 2026 Total Revenues, Medical Margin, and Adjusted EBITDA Guidance Westerville, O.H., August 5, 2026 – agilon health, inc.
EX-99.1 2 agl-20260630xexx991.htm EX-99.1 Document Exhibit 99.1 agilon health Reports Second Quarter 2026 Results Revenue increase 7% to $1.49 billion Raises Full-Year 2026 Total Revenues, Medical Margin, and Adjusted EBITDA Guidance Westerville, O.H., August 5, 2026 – agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the second quarter ended June 30, 2026. In addition, the company increased full-year 2026 guidance for total revenues, medical margin, and Adjusted EBITDA. “Our second quarter results exceeded our expectations, demonstrating meaningful progress across agilon's strategic initiatives and reinforcing our confidence in the strength of our Total Care Model,” said Tim O’Rourke, Chief Executive Officer of agilon health. “We are raising our full-year 2026 outlook which reflects stronge...
Source
Exhibit EX-99.1
0001628280-26-053328
Filed August 5, 2026 at 8:07 PM UTC. The figures above are from the audited statements, not from this release.